Industry Executive Insights Summary: 2025 Finance & Budget Priorities - Health System Leaders Share What’s Ahead

Industry Executive Insights Summary: Health System Finance Priorities Shaping Therapy Access and Adoption

Key Insights from the Health System Finance Executive Survey Results

THMA conducted a double‑blind survey of 40 CFOs and VPFs from large U.S. health systems (over $750M in annual revenue) to uncover the financial pressures and budget priorities influencing therapy access and adoption. We’re sharing a limited‑time summary to provide pharmaceutical teams with timely, decision‑relevant market intelligence.

Download our Industry Executive Insights Summary to:

• Gain exclusive insights on investment priorities, evolving care models, and long‑term financial sustainability that influence product adoption

• Understand how health systems are navigating pressures across patient access, revenue, cost, and workforce that impact formulary and pathway decisions

• Explore the federal policy changes with the greatest financial impact, from Medicaid reform to 340B drug pricing and site‑neutral payments, and how they shape therapy adoption feasibility

We will contact you with more information.